Answers are grounded in this paper and cite their sources.
Thrombin activity is increased in vitreous of patients with established PVR and is involved in the activation of proinflammatory and profibrotic pathways in RPE cells. Inhibition of thrombin activity may therefore represent a potential treatment option for proliferative vitreoretinopathy.
No takes yet. Share an insight, caveat, or question.
Bastiaans et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: